Category Archives: Zocor

Featured Stories

Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings

Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, ...

Read More

Do Vitamin Drinks Pose Health Risks?Do Vitamin Drinks Pose Health Risks?

Do Vitamin Drinks Pose Health Risks?

Scientists are concerned vitamin drinks are contributing to levels of vitamins and other nutrients that are not only unnecessary, but potentially harmful.

Read More

Johnson & Johnson’s Ethicon Division to End Sales of Gynecare Prolift, Three Other Transvaginal Mesh Devices

Johnson & Johnson’s Ethicon Inc. division revealed yesterday that it will end sales of its Gynecare Prolift device and three other transvaginal mesh products. The plan to stop selling the four products was set forth in a letter filed by the company in the Ethicon transvaginal mesh multidistrict litigation ...

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

E. District of Missouri denied motion to dismiss conspiracy claims. Lawsuit alleges the defendants conspired to misrepresent true dangers with use of talcum powder.

Read More

Lawsuits over DePuy ASR Metal-on-Metal Hip Implants Continue to Mount

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be hit with lawsuits over recalled metal-on-metal DePuy ASR hip implants. Just yesterday, the national law firm of Parker Waichman LLP announced it had filed yet another DePuy ASR hip implant lawsuit, this time on behalf of a Virginia resident ...

Read More

Exploding Tanks Kill Jeep Drivers 18 months after Recall

Exploding Gas Tanks Continue to Kill Jeep Drivers 18 months after Recall

Chrysler recalled Jeeps with exploding gas tanks more than 18 months ago, but 1 million+ of these vehicles have not been fixed as the death toll continues to rise.

Read More

Study Shows Increased Risk of Type 2 Diabetes for Statin Users

Increased Risk of Type 2 Diabetes for Statin Users

A new study from Finland has confirmed previous findings about a link between the use of cholesterol-lowering statin drugs and higher risk of Type 2 diabetes. This study, published in the journal Diabetologia, avoided some of the limitations of earlier … Continue reading

Posted in Health Concerns, Pharmaceuticals, Zocor | Tagged , , , |

Statins May Raise Risk of Cataracts

New Canadian research shows that cholesterol-lowering statin drugs may raise the risk of developing cataracts, a clouding of the lens of the eye. While statins such as Zocor (simvastatin), Crestor (rosuvastatin), and Lipitor (atorvastatin) protect many people from heart attack … Continue reading

Posted in Crestor, Health Concerns, Pharmaceuticals, Zocor |

Statin Drugs Increase Risk of Diabetes

According to a study just published online in the medical journal the Lancet, cholesterol-lowering statin drugs can directly increase the risk of diabetes. While statins have previously been associated with higher rates of Type 2 diabetes, it was not clear … Continue reading

Posted in Birth Defects, Crestor, Health Concerns, Pharmaceuticals, Zocor |

New Research Identifies Serious Design Flaws in Many Animal-Based Drug Studies

animal-testing-flawed-statin-drugs

Recently published research reports serious design flaws in many of the pharmaceutical studies involving animals that precede drug trials in humans. A research team led by pharmacologist Lisa Bero of the University of California, San Francisco, analyzed animal studies of … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor |

Study: Statins May Reduce Exercise Benefits in Overweight, Obese Adults

Statins_Affect_Excercise

A new study has found that statins, used to lower blood cholesterol levels, may reduce exercise benefits for overweight adults. Statins rank among the best selling drugs in the world and are typically prescribed to people with obesity, diabetes, and … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor |

Study: High-Dose Statins Linked to Acute Kidney Injury

A recent BMJ article reviewed the connection between statin medications and kidney damage. The just-published article reviewed data from over 2 million patient records dated from 1997 to 2008, said the Drug Safety Monitor. Records originated from Canadian provinces and … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor |

Age-Related Cataracts Linked to Statin Use

People who use statins to lower their cholesterol may face a higher risk of developing age-related cataracts, according to a new study that appears in the August issue of Optometry and Vision Science.  According to the study, the association between … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor | Tagged |

More Potent Statins Linked to Muscle Damage

Statin drugs prescribed to lower cholesterol levels are more likely to cause severe muscle injuries when taken at higher doses or when more potent forms of the drug are used. According to a ScienceDaily.com report on a new study from … Continue reading

Posted in Pharmaceuticals, Zocor | Tagged |

Statins May Leave Patients Fatigued, Study Finds

Cholesterol-lowering statins may leave patients fatigued, according to a new study. Statins are a class of prescription drugs used in combination with diet and exercise to lower the blood levels of low-density lipoprotein (LDL) cholesterol—so-called bad cholesterol. The research found … Continue reading

Posted in Pharmaceuticals, Zocor | Tagged |

FDA Warns Of Statin Interactions With HIV, Hepatitis C Drugs

The U.S. Food and Drug Administration (FDA) issued a warning concerning statin interactions with HIV and hepatitis C medications. The notification involved interactions between protease inhibitors and certain statin drugs, including Lipitor (Atorvastatin), Mevacor (Lovastatin), Crestor (Rosuvastatin), and Zocor (Simvastatin). … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.